Braze (BRZE) Could Be 30% Undervalued As Goldman Sachs Starts Coverage With Buy

Attention around Braze (BRZE) has picked up after Goldman Sachs initiated coverage, pointing to accelerating demand for the company’s AI powered customer engagement tools, along with its recent fiscal first quarter 2027 results and billings growth.

See our latest analysis for Braze.

At a share price of $24.15, Braze has seen short term momentum pick up, with a 7 day share price return of 15.16% and a 90 day share price return of 7.86%. However, the year to date share price return is down 25.81% and the 3 year total shareholder return is down 43.42%, pointing to improving interest after a weaker longer term experience for shareholders.

If this AI themed move has your attention, it could be a good moment to see what else is gaining traction in the sector with the 62 profitable AI stocks that aren't just burning cash.

The rebound in Braze comes alongside a share price well below both analyst targets and some fair value estimates. This raises the question of whether this is a mispriced opportunity or the market is simply applying justified caution to the story.

Most Popular Narrative: 29.8% Undervalued

Against Braze's last close of $24.15, the most followed narrative points to a fair value of $34.40 and frames that gap around AI driven growth and margin potential.

Braze's acquisition of OfferFit is expected to enhance AI driven optimization capabilities and lead to revenue growth through deal size expansion and differentiation in the market. This investment should drive better earnings and net margins as OfferFit's sophisticated AI solutions integrate into Braze's platform.

Read the complete narrative.

If you want to understand why this narrative supports a higher value for Braze, focus on how it links faster revenue growth, improving margins, and a richer earnings profile to a future profit multiple that sits above many US software peers.

Result: Fair Value of $34.40 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Braze still faces real execution questions, including OfferFit integration risks and higher costs from evolving data rules that could pressure margins and challenge the optimistic narrative.

Find out about the key risks to this Braze narrative.

Next Steps

With both risks and potential rewards in play for Braze, this is a good moment to move quickly, review the full picture, and weigh the 3 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Braze?

Do not stop at Braze alone. Broaden your watchlist with focused stock ideas that match different goals, risk levels, and income needs using the Simply Wall Street Screener.

• Target long term compounding potential by scanning for companies that look mispriced on quality and fundamentals through the 41 high quality undervalued stocks.
• Strengthen the defensive side of your portfolio by searching for businesses with robust balance sheets and fundamentals using the solid balance sheet and fundamentals stocks screener (47 results).
• Build a stream of income focused holdings by zeroing in on higher yielding opportunities with the 8 dividend fortresses.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com